AG真人官方

SBC Medical to Announce Q2 2025 Financial Results and Hold Conference Call on August 13, 2025

IRVINE, Calif.--(BUSINESS WIRE)-- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (鈥淪BC Medical鈥� or the 鈥淐ompany鈥�), a global franchise and provider of services for aesthetic clinics, today announced that it will report its Q2 2025 financial results on Wednesday, August 13, 2025, before the U.S. market opens.

The Company will hold a conference call on Wednesday, August 13, 2025 at 8:30 am Eastern Time (or Wednesday, August 13, 2025 at 9:30 pm Japan Time) to discuss the financial results and take questions live.

Please register in advance of the conference using the link provided below.

It will automatically direct you to the registration page of 鈥淪BC Q2 2025 Financial Results Presentation.鈥� Please follow the steps to enter your registration details, then click 鈥淪ubmit.鈥� Upon registration, you will be able to access the dedicated Conference Call viewing site. In addition to viewing the conference call, this site provides access to information about the speakers as well as past investor relations materials.

Starting 10 minutes before the conference call begins, you will be able to view the earnings presentation materials on the site. The materials will also be available for download. A replay of the conference call will be accessible until August 13, 2026. Additionally, the earnings release, accompanying slides, and an archived webcast of this conference call will be available at the Company鈥檚 Investor Relations website at

About SBC Medical

SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensing of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic鈥檚 customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics. For more information, visit

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company鈥檚 beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company鈥檚 control. These forward-looking statements reflect the Company鈥檚 current views with respect to, among other things, the Company鈥檚 product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as 鈥渕ay,鈥� 鈥渟hould,鈥� 鈥渆xpects,鈥� 鈥渁nticipates,鈥� 鈥渃ontemplates,鈥� 鈥渆stimates,鈥� 鈥渂elieves,鈥� 鈥減lans,鈥� 鈥減rojected,鈥� 鈥減redicts,鈥� 鈥減otential,鈥� 鈥渢argets鈥� or 鈥渉opes鈥� or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management鈥檚 current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading 鈥淩isk Factors鈥� and elsewhere in the Company鈥檚 filings with the U.S. Securities and Exchange Commission (the 鈥淪EC鈥�), which are accessible on the SEC鈥檚 website at .

View source version on businesswire.com:

SBC Medical Group Holdings Incorporated (Asia)

Hikaru Fukui / Head of Investor Relations

E-mail: [email protected]

Akiko Wakiyama / Head of Public Relations

E-mail: [email protected]

ICR LLC (In the US)

Bill Zima / Managing Partner

Email: [email protected]

Source: SBC Medical Group Holdings Incorporated